To estimate the contribution of clinical features and AD-core biomarkers in modulating the levels of synaptic-related biomarkers, we firstly performed a univariate regression analysis, separately considering the contribution of Ng, α-Syn, Aβ 42/Ng and Aβ 42/α–Syn. Here, NRGN is linked to Alzheimer disease.